GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 79 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2016. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $14,953,000 | +1.2% | 1,552,740 | +24.4% | 1.60% | +3.3% |
| Q2 2017 | $14,770,000 | +7.0% | 1,248,508 | +15.9% | 1.55% | +2.7% |
| Q1 2017 | $13,810,000 | +31.3% | 1,077,196 | +25.4% | 1.51% | +44.0% |
| Q4 2016 | $10,518,000 | -36.3% | 859,349 | -38.5% | 1.05% | -38.8% |
| Q3 2016 | $16,500,000 | +25.4% | 1,398,288 | -7.6% | 1.71% | +10.0% |
| Q2 2016 | $13,161,000 | +149.2% | 1,512,734 | +50.9% | 1.56% | +137.0% |
| Q1 2016 | $5,282,000 | -44.8% | 1,002,262 | -17.6% | 0.66% | -47.9% |
| Q4 2015 | $9,574,000 | 0.0% | 1,216,481 | 0.0% | 1.26% | +0.8% |
| Q3 2015 | $9,574,000 | – | 1,216,481 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|